Paternal glatiramer acetate use not associated with increased risks of adverse pregnancy or fetal outcomes

Researchers from TEVA pharmaceuticals have published a small case series describing 232 prospective cases of paternal glatiramer acetate use, and the associated pregnancy and fetal outcomes, as extracted from the Teva Global Pharmacovigilance database. More information is available here.

Photo by OPPO Find X5 Pro on Unsplash